The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
azacitidine
A pyrimidine nucleoside analogue of cytidine with antineoplastic activity. Azacitidine is incorporated into DNA, where it reversibly inhibits DNA methyltransferase, thereby blocking DNA methylation. Hypomethylation of DNA by azacitidine may activate tumor suppressor genes silenced by hypermethylation, resulting in an antitumor effect. This agent is also incorporated into RNA, thereby disrupting normal RNA function and impairing tRNA cytosine-5-methyltransferase activity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | 5-AC 5-azacytidine azacytidine ladakamycin | |
| |||
| US brand names: | | Mylosar Vidaza | |
| |||
| Abbreviations: | | 5-AC 5-AZC | |
| |||
| Code name: | | U-18496 | |
| |||
| Chemical structure: | | 4-amino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one | |
| |||
